ENTERO vs LENSKART: Stock Comparison
LENSKART SOLUTIONS is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows a lower P/E, while LENSKART SOLUTIONS shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ENTERO leads 6; LENSKART leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ENTERO | LENSKART |
|---|---|---|
| Sector | Consumer Services | Consumer Services |
| Industry | Pharmacy Retail | Speciality Retail |
Price
| Metric | ENTERO | LENSKART |
|---|---|---|
| Live Price | ₹1,797.4 | ₹668.9 |
| Day Change | -0.42% | 0.78% |
| Volume | 1.67 L | 87.67 L |
| 52-Week High | ₹1,841.5 | ₹674.9 |
| 52-Week Low | ₹944 | ₹356.1 |
| Distance from 52W High | -2.39% | -0.89% |
Valuation
| Metric | ENTERO | LENSKART |
|---|---|---|
| Market Cap | ₹7,834 Cr | ₹1.16 L Cr |
| P/E Ratio | 62.47x | 176.13x |
| P/B Ratio | 4.64x | 13.2x |
| EPS | ₹28.78 | ₹0.87 |
| Book Value | ₹388.09 | ₹50.91 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ENTERO | LENSKART |
|---|---|---|
| Revenue Growth (TTM YoY) | 42.6% | 45.6% |
| EPS Growth (TTM YoY) | 9.1% | -10.8% |
| Qtr Sales Growth | 2,230.48% | -43.83% |
| Qtr Profit Growth | 1,405.67% | -33.69% |
Profitability & Leverage
| Metric | ENTERO | LENSKART |
|---|---|---|
| ROE | 1.6% | 9.2% |
| ROCE | 2.01% | 11.89% |
| Net Margin | 1.75% | 5.6% |
| Operating Margin | 9.99% | 11.92% |
| Debt to Equity | 0.06x | 0.02x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ENTERO | LENSKART |
|---|---|---|
| Promoter Holding | 14.4%▼ 0.01 pp | 17.53%▼ 0.02 pp |
| FII Holding | 4.37%▲ 0.34 pp | 12.76%▲ 8.5 pp |
| DII Holding | 15.48%▼ 1.14 pp | 23.57%▲ 8.09 pp |
| Public Holding | 27.75%▲ 0.82 pp | 45.72%▼ 16.57 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and LENSKART SOLUTIONS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.